Successful treatment with tralokinumab in patients with atopic dermatitis and dupilumab-induced psoriasis

J Eur Acad Dermatol Venereol. 2023 Dec;37(12):e1432-e1434. doi: 10.1111/jdv.19351. Epub 2023 Jul 24.

Authors

L Quattrini^{1

2}, G Caldarola^{1

2}, G M Falco^{1

2}, L M Pinto^{1

2}, K Peris^{1

2}

Affiliations

¹ Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
² UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.

PMID: 37458532
DOI: 10.1111/jdv.19351

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal / adverse effects
Dermatitis, Atopic* / drug therapy
Humans
Psoriasis* / chemically induced
Psoriasis* / drug therapy
Severity of Illness Index
Treatment Outcome

Substances

tralokinumab
dupilumab
Antibodies, Monoclonal